Stockreport

Wainwright likes Mirati, Buy rating and $12 price target [Seeking Alpha]

Mirati Therapeutics, Inc.  (MRTX) 
Last mirati therapeutics, inc. earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mirati.com/node/5806
PDF H.C. Wainwright initiates coverage of Mirati Therapeutics (NASDAQ: MRTX ) with a Buy rating and $12 (112% upside) price target. Now read: Merck KGaA 2016 Q3 - [Read more]